Downregulation of DDX3X enhanced proliferation, migration and invasion of CRC cells in vitro and enhanced tumor metastasis in vivo by inhibiting E-cadherin and activating β-catenin signaling via suppressing the MAPK pathway (81, 82) (Figure 8). Here, DDX3X is linked to neoplasm.